ABL1 and graft versus host disease: In addition, manipulation of the relevant signaling cascades and/or GPNMB expression or function may constitute a promising strategy in combinatory approaches using BCR-ABL TKI and DC-based immunotherapy and may also allow for manipulation of T cell responses in GvHD.